1. Home
  2. DSP vs EBS Comparison

DSP vs EBS Comparison

Compare DSP & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viant Technology Inc.

DSP

Viant Technology Inc.

N/A

Current Price

$11.85

Market Cap

272.1M

Sector

Technology

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.78

Market Cap

303.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSP
EBS
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.1M
303.3M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
DSP
EBS
Price
$11.85
$5.78
Analyst Decision
Strong Buy
Buy
Analyst Count
11
3
Target Price
★ $19.32
$10.00
AVG Volume (30 Days)
394.1K
★ 1.1M
Earning Date
11-09-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 157.14
125.83
EPS
★ N/A
N/A
Revenue
$344,201,000.00
★ $742,900,000.00
Revenue This Year
$26.65
N/A
Revenue Next Year
$21.65
$7.03
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 19.00
N/A
52 Week Low
$8.72
$4.36
52 Week High
$14.80
$14.06

Technical Indicators

Market Signals
Indicator
DSP
EBS
Relative Strength Index (RSI) 42.04 38.19
Support Level $9.75 $5.51
Resistance Level $12.45 $6.83
Average True Range (ATR) 0.82 0.45
MACD -0.21 -0.06
Stochastic Oscillator 28.69 15.04

Price Performance

Historical Comparison
DSP
EBS

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: